VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DBD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DBDDiebold Nixdorf, Incorporated
$58.27$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. DBD
  4. Financial Ratios

Diebold Nixdorf, Incorporated (DBD) Financial Ratios

Latest Ratios: P/E Ratio 26.3x · EV/EBITDA 6.8x · ROE 9.3%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

DBD Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$2.0B$2.5B$1.6B$1.9B———————
Enterprise Value$2.8B$3.3B$2.4B$2.7B———————
P/E Ratio →26.2926.73—1.35———————
P/S Ratio0.500.660.430.50———————
P/B Ratio1.962.291.721.73———————
P/FCF14.159.5912.28————————
P/OCF6.588.4010.85————————

P/E links to full P/E history page with 30-year chart

DBD EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.870.630.71———————
EV / EBITDA6.797.177.5411.96———————
EV / EBIT8.2615.9811.6917.97———————
EV / FCF—12.5817.98————————

DBD Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin26.4%26.4%24.5%23.3%21.9%26.7%26.5%24.4%19.5%22.3%22.5%
Operating Margin8.8%8.8%4.9%2.3%-6.1%3.5%0.6%5.3%-7.9%2.9%1.8%
Net Profit Margin2.5%2.5%-0.4%36.6%-16.8%-2.0%-6.9%-7.7%-12.4%-5.2%-5.4%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE9.3%9.3%-1.6%127.5%————-120.3%-23.6%-23.7%
ROA2.6%2.6%-0.4%38.1%-17.7%-2.2%-7.2%-8.4%-11.9%-4.6%-4.7%
ROIC14.0%14.0%7.6%4.4%-14.0%8.0%1.2%10.4%-13.1%4.5%3.1%
ROCE14.1%14.1%7.3%4.1%-13.2%7.3%1.1%9.5%-11.8%3.9%2.6%

DBD Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.061.061.121.26—————1.901.68
Debt / EBITDA2.542.543.336.08—8.5612.215.01—4.789.21
Net Debt / Equity—0.710.800.75—————1.351.07
Net Debt / EBITDA1.701.702.393.62—7.2010.624.40—3.385.87
Debt / FCF—2.995.70——28.63—21.85———
Interest Coverage2.422.421.300.60-1.200.74-0.01-0.16-2.09-0.67-1.40

DBD Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.301.301.321.521.101.081.131.181.401.381.44
Quick Ratio0.920.920.901.100.740.770.820.891.020.981.03
Cash Ratio0.300.300.250.400.210.240.220.180.250.350.39
Asset Turnover—0.991.060.901.131.111.071.161.060.880.63
Inventory Turnover5.385.385.364.894.605.265.767.146.045.013.48
Days Sales Outstanding—58.4557.2670.0664.5755.6360.5151.2858.7765.56101.38

DBD Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield3.8%3.7%—73.9%———————
FCF Yield7.1%10.4%8.1%————————
Buyback Yield6.6%5.2%0.0%0.0%———————
Total Shareholder Yield6.6%5.2%0.0%0.0%———————
Shares Outstanding—$37M$38M$64M$79M$78M$78M$77M$76M$76M$69M

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Thin margins and leverage exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Low Multiples Reflect Earnings Skepticism

Based on reported figures, DBD trades at 22.9x trailing earnings but only 12.5x forward and 5.98x EV/EBITDA, a sizable gap suggesting the market doubts the durability of the recent earnings recovery. Investors should monitor whether forward estimates hold.

The compression from trailing P/E of 22.94 to forward P/E of 12.46 implies that analysts expect substantially higher earnings, yet the trailing figure is depressed by volatile quarterly net income swings. The EV/EBITDA of 5.98 against a P/S of 0.52 indicates a valuation anchored to operating cash generation rather than revenue, which is consistent with thin net margins and a heavy debt load. The low P/FCF of 7.51 is less reassuring given that free cash flow has been negative in several recent quarters, so the cheapness may reflect risk rather than mispricing.

Gross Margin Stable, Operating Leverage Fragile

As reported in financial statements, DBD's gross margin held between 23.9% and 27.1% over ten quarters, yet operating margin fell from 11.6% in 2025Q4 to 3.9% in 2026Q3, exposing weak conversion of gross profit.

The stability of gross margin suggests pricing and product mix are relatively steady, so the volatility sits below the gross line. The collapse in operating margin while gross margin remained near 25% points to rising operating costs or unfavorable revenue timing rather than a structural pricing problem. Net margin below 1% in the latest two quarters means earnings power is thin enough that modest cost shocks could erase profitability.

Leverage Ratios Rise as Coverage Erodes

Based on reported figures, DBD's debt-to-EBITDA stands near 15.7x in 2026Q3 against interest coverage of only 1.57x, a combination that warrants further investigation into debt service comfort.

Debt-to-EBITDA has fluctuated between roughly 7x and 16x, with the most recent reading reflecting compressed operating earnings rather than meaningful debt reduction. Interest coverage near 1.5x leaves little cushion, so debt service may become more demanding if operating income does not recover. Refinancing exposure appears elevated, though the filings provided do not disclose maturity schedules or covenant terms, so this conclusion should be treated as an inference.

Current Ratio Steady Beneath Cash Drain

According to recent SEC filings as summarized here, DBD's current ratio held near 1.27 to 1.30 recently, but a quick ratio near 0.84 and sharply declining cash suggest a limited buffer under stress.

A current ratio above 1 is maintained largely through receivables and inventory rather than cash, as the quick ratio below 0.9 indicates. Cash falling toward the low hundreds of millions while current obligations remain substantial suggests the liquidity cushion is thinning. Under a severe working capital reversal, the company may have limited room absent additional financing, though available credit facilities are not disclosed in the supplied data.

Lagging Peer on Returns and Multiples

Based on EDBL-reported peer data, DBD's ROE and net margin trail NATL's 49.2% ROE and 3.7% net margin, while DBD carries a far higher debt-to-equity ratio near 1.2.

NATL achieves substantially higher returns on equity with a comparable net margin, which suggests a more efficient capital structure or stronger equity base relative to earnings. DBD's leverage near 1.2x debt-to-equity versus NATL's 7.2x is notable, though NATL's figure may reflect a different equity base and should be read cautiously. The gap appears partly structural, tied to leverage and asset intensity, rather than purely temporary.

Headline Multiples May Mask Leverage Risk

Bearish analysis based on reported figures suggests the low EV/EBITDA of 5.98 may understate risk, since debt-to-EBITDA near 15.7x in 2026Q3 implies EBITDA quality or debt levels warrant closer scrutiny than the headline multiple alone conveys.

A low EV/EBITDA can look attractive when EBITDA is elevated, but the sharp recent swing in debt-to-EBITDA indicates reported EBITDA may be cyclical or temporarily strong relative to the debt load. The P/B of 1.96 sits uneasily beside a debt-to-equity ratio near 1.2, suggesting book value is supported more by liabilities than by a deep equity cushion. Investors should monitor whether the apparent discount persists once operating income normalizes, rather than treating current multiples as evidence of mispricing.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open DBD Terminal

DBD Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DBD — Frequently Asked Questions

Quick answers to the most common questions about buying DBD stock.

What is Diebold Nixdorf, Incorporated's P/E ratio?

Diebold Nixdorf, Incorporated's current P/E ratio is 26.3x. The historical average is 14.0x. This places it at the 50th percentile of its historical range.

What is Diebold Nixdorf, Incorporated's EV/EBITDA?

Diebold Nixdorf, Incorporated's current EV/EBITDA is 6.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.9x.

What is Diebold Nixdorf, Incorporated's ROE?

Diebold Nixdorf, Incorporated's return on equity (ROE) is 9.3%. The historical average is 6.2%.

Is DBD stock overvalued?

Based on historical data, Diebold Nixdorf, Incorporated is trading at a P/E of 26.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Diebold Nixdorf, Incorporated's profit margins?

Diebold Nixdorf, Incorporated has 26.4% gross margin and 8.8% operating margin.

How much debt does Diebold Nixdorf, Incorporated have?

Diebold Nixdorf, Incorporated's Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.